There is a presence of several components in these berries which contribute in improving memory and reduce the risk
of cognitive diseases.
The main benefits of this supplement relate to metabolic and cardiovascular health, as well as a significant decrease in the risk
of cognitive disease and some types of cancer.
Not exact matches
«Through this collaboration with the cancer community's leading clinical and pathology experts, thousands
of more patients can potentially benefit from the world's growing body
of knowledge about this
disease,» said IBM Research and
Cognitive Solutions senior vice president John Kelly in a statement.
Fernando Pagan, a GUMC associate professor
of neurology who directs the Movement Disorders Program at MedStar Georgetown University Hospital, said that to his knowledge, the study «represents the first time a therapy appears to reverse — to a greater or lesser degree depending on stage
of disease —
cognitive and motor decline in patients with these neurodegenerative disorders.»
Studies have shown that walking more lowers risks
of chronic
diseases such as high blood pressure, which is linked with decreased
cognitive function.
Walking reduces depression, lowers your risk
of diabetes, cancer, depression, and heart
disease, slows down the aging process, and improves
cognitive abilities.
I didn't start to regain my pre-cancer
cognitive and physical functioning until about nine months after hearing my oncologist say, «no evidence
of disease.»
Though it's still being understood, doctors have identified a series
of very serious conditions linked to the
disease: depression,
cognitive impairment, suicidal thoughts and behavior, aggression, short - term memory loss, difficulty walking, dementia and, yes, substance abuse.
Turmeric is powerful enough to treat cancer, increase
cognitive function and lower your risk
of heart
disease.
Relieving stress and anxiety can also help reduce your chances
of heart
disease, hormonal imbalance, insomnia,
cognitive decline, and premature aging.
A Drink Might Boost Cognition and Creativity, and Potentially Fight Off the Flu A study published in the Journal
of Alzheimer's
Disease finds evidence that adults who drink moderately and regularly have a higher chance
of not only living longer, but doing so without developing dementia or other
cognitive impairment...
Offering her support for its health and holistic benefits, Dorit Adler, the chief clinical dietician
of Hadassah University Medical Center, said: «The evidence - based research proves again and again that the [low - meat] Mediterranean diet lowers the risks
of most
of the modern
diseases from obesity through diabetes, heart
disease and even
cognitive impairment.
Long - term studies
of both problems and potential benefit
of Kona coffee drank by elderly people, including assessment on symptoms
of Alzheimer's
disease and
cognitive impairment, are not conclusive.
Ingesting aluminum is pretty conclusively linked to increased risk
of Alzheimer's
disease and general
cognitive decline.
Long - term studies
of both risk and potential benefit
of drinking Kona by elderly people, including assessment on symptoms
of Alzheimer's
disease and
cognitive impairment, are not conclusive.
Studies have shown that among the many effects
of physical abuse are depression, anxiety,
cognitive and learning difficulties, even a lowering
of IQ (especially verbal IQ), disordered sleep, flashbacks, loss
of empathy, aggressive behavior, chronically high stress levels which can lead to chronic health effects such as high blood pressure and increased risk
of cardiovascular
disease, and inability to maintain relationships.
Articles explore: the idea that violence should be thought
of as a public health problem analogous to infectious
disease; examine from a scientific perspective the impacts on children's social, emotional, and
cognitive development
of growing up in a violent community; share first - hand insights from children and caregivers; and explore various interventions, from the favelas
of Recife, Brazil, to the inner cities
of Chicago, Illinois, United States (US), and Glasgow, Scotland, which are offering a tangible sense
of hope.
What we don't have to wait for is knowing that breastfeeding can and does make a difference, not only with decreasing the risk
of respiratory
diseases and allergies but with
cognitive (intellect) development as well.
Students enrolled in NutriBullet University have seen a variety
of health improvements such as a decrease in total cholesterol levels, improved
cognitive function and a decreased risk for lifestyle
diseases.
An older study in the Archives
of Disease of Childhood found that prolonged crying was associated with adverse
cognitive development.
These include increased prevalence
of a range
of infectious
diseases and health conditions — ear infections, gastrointestinal infections respiratory infections, necrotizing enterocolitis, sepsis, meningitis, diabetes, childhood cancers, obesity, allergies — formula fed infants grow and develop differently from breastmilk fed infants, including
cognitive and neural development.
Research in the United States, Canada, Europe, and other developed countries, among predominantly middle - class populations, provides strong evidence that human milk feeding decreases the incidence and / or severity
of diarrhea,1 - 5 lower respiratory infection,6 - 9 otitis media,3,10 - 14bacteremia, 15,16 bacterial meningitis, 15,17 botulism, 18 urinary tract infection, 19 and necrotizing enterocolitis.20, 21 There are a number
of studies that show a possible protective effect
of human milk feeding against sudden infant death syndrome,22 - 24insulin - dependent diabetes mellitus,25 - 27 Crohn's
disease, 28,29 ulcerative colitis, 29 lymphoma, 30,31 allergic diseases,32 - 34 and other chronic digestive diseases.35 - 37 Breastfeeding has also been related to possible enhancement
of cognitive development.38, 39
Breastfeeding has many benefits that include protecting the baby against inflammatory
diseases of the gut, lungs or ears, and longer term health problems such as diabetes and obesity, improved
cognitive outcomes, and protecting the mother against breast cancer.
Breastfeeding has been linked to numerous benefits for the health, growth and development
of infants, including fewer infections,
diseases, and possible increased
cognitive development.
Many epidemiologic studies consistently show that breastfeeding not only provides optimal bio-avaiable nutrients, but also protects against diarrhoeal, respiratory and other
diseases [11][12][13][14], including the non-communicable
disease of obesity in later life [15][16][17] and leads to improved
cognitive and psychosocial outcomes [18][19][20].
Ay 10:30 a.m., sen. David Carlucci, Rep. Steve Israel, Rep. Nita Lowey, and Assemblyman Charles Lavine will hold an Alzheimer's
Disease and Neuroscience Research Roundtable with experts from the Nathan Kline Institute, Feinstein Institute, Mount Sinai Center for
Cognitive Health and the Alzheimer's Association
of the Hudson Valley, Ellipse Lecture Hall, Rockland Community College, 145 College Rd., Suffern.
Although Alzheimer's
disease is probably the most recognized cause
of dementia, HS - AGING also causes serious
cognitive impairment in older adults.
The researchers speculate that this could underlie
cognitive problems
of the
disease, which can persist despite treatment
of seizures.
It is important for physicians and scientists to understand the unique pathology
of HS - AGING, and to be able to differentiate it from other
diseases, as it is only by making an accurate diagnosis that clinicians can hope to treat people who present with signs
of cognitive decline.
«
Cognitive aging is not a
disease or a level
of impairment — it is a lifelong process that affects everyone,» explains lead author Dr. Sharon K. Inouye, Director
of the Aging Brain Center at the Institute for Aging Research, Hebrew SeniorLife in Boston, Massachusetts and Professor
of Medicine, Harvard Medical School.
An expert panel convened by the Institute
of Medicine clarified the
cognitive aging process by making a distinction from Alzheimer
disease and related dementias, and provided recommendations to enhance
cognitive health in older adults.
Marilyn Albert is the Director
of the Division
of Cognitive Neuroscience in the Department
of Neurology at Johns Hopkins University School
of Medicine and Director
of the Johns Hopkins Alzheimer's
Disease Research Center.
The brains
of the super-agers showed less cortical thinning, or neuron loss in certain areas, said lead researcher Emily Rogalski, research associate professor at the
Cognitive Neurology and Alzheimer's
Disease Center, Northwestern University Feinberg School
of Medicine in Chicago.
The study also linked traumatic brain injury with the onset
of neurodegenerative disorders, including mild
cognitive impairment as well as Alzheimer's and Parkinson's
diseases.
«We found that physical activity has the potential to preserve the volume
of the hippocampus in those with increased risk for Alzheimer's
disease, which means we can possibly delay
cognitive decline and the onset
of dementia symptoms in these individuals.
In the meantime, those with AB blood need not panic about their future
cognitive wherewithal, she says, noting that all our brains are apt to benefit from a healthy diet, awareness
of our risk factors for heart
disease and stroke, and regular exercise for the body and brain.
Because there is still no accepted biomarker for aging, the drug's success would be judged by whether it can delay the development
of several
diseases whose incidence increases dramatically with age: cardiovascular
disease, cancer, and
cognitive decline, along with mortality.
Researchers used accelerometers to measure the daily physical activity
of participants, all
of whom are in late middle - age and at high genetic risk for Alzheimer's
disease, but presently show no
cognitive impairment.
«Unfortunately, most clinical trials to date have focused on patients whose
cognitive deficits are already mild to severe, and when the therapeutic opportunities in this late stage
of the
disease are minimal.
Both he and a younger sister with mild
cognitive problems, have two copies
of a mutation in a gene called APP, while relatives with just one copy
of the mutation, including an 88 - year - old aunt, seemed to be actively protected against the
disease (Science, DOI: 10.1126 / science.1168979).
Huntington's
disease is a brain disorder characterized by the emergence
of decreased motor,
cognitive, and psychiatric abilities, most commonly appearing in the mid-30s and 40s.
«Now that we have more evidence that serotonin is a chemical that appears affected early in
cognitive decline, we suspect that increasing serotonin function in the brain could prevent memory loss from getting worse and slow
disease progression,» says Gwenn Smith, Ph.D., professor
of psychiatry and behavioral sciences at the Johns Hopkins University School
of Medicine and director
of geriatric psychiatry and neuropsychiatry at Johns Hopkins University School
of Medicine.
Jim Monti (right) a postdoctoral research associate in the lab
of Illinois psychology professor Neal Cohen (left), developed a
cognitive task that helps differentiate older adults with very early Alzheimer's
disease from those experiencing normal aging.
«Brain scan study adds to evidence that lower brain serotonin levels are linked to dementia: Results suggest serotonin loss may be a key player in
cognitive decline, not just a side - effect
of Alzheimer's
disease.»
Previous studies from Johns Hopkins and other centers have shown that people with Alzheimer's
disease and severe
cognitive decline have severe loss
of serotonin neurons, but the studies did not show whether those reductions were a cause or effect
of the
disease.
If dozens
of human and animal studies published over the past six years are borne out by large clinical trials, nicotine — freed at last
of its noxious host, tobacco, and delivered instead by chewing gum or transdermal patch — may prove to be a weirdly, improbably effective drug for relieving or preventing a variety
of neurological disorders, including Parkinson's
disease, mild
cognitive impairment (MCI), Tourette's and schizophrenia.
Cognitive decline is among the most dreaded consequences
of old age and
disease.
Ten weeks
of intravenous antibiotics improved
cognitive functioning in Lyme
disease patients in a 2004 study funded by the National Institutes
of Health and carried out by psychiatrist Brian Fallon at Columbia University.
«That was illuminating and will serve to inform future work aimed at understanding and detecting the earliest
cognitive manifestations
of Alzheimer's
disease,» Monti said.
The neuroprotective effects
of nicotine were studied in a randomized clinical trial involving 67 subjects in the early stages
of Alzheimer's
disease, where memory was slightly impaired but decision - making and other
cognitive abilities remained intact.